Amicus Therapeutics, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Amicus Therapeutics, Inc. opposed by its competitors

Patent:
Grant Date:
Sep 1, 2021
Title:
Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The Gla Gene
Oppositions:
2
Patent:
Grant Date:
Apr 22, 2020
Title:
Dosing Regimens For The Treatment Of Fabry Disease
Oppositions:
1

Competitors of Amicus Therapeutics, Inc.

TEVA PHARMACEUTICAL INDUSTRIES LTD

GILL JENNINGS & EVERY LLP

Want to track Amicus Therapeutics, Inc.?

Feel free to send us a message here and we will get back to you